Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Peking Union Medical College Hospital
University of Southern California
University of Pennsylvania
Baptist Health South Florida
University of Chicago
Sichuan Enray Pharmaceutical Sciences Company
Children's Hospital of Philadelphia
Dana-Farber Cancer Institute
Essen Biotech
Essen Biotech
Centre Leon Berard
University of Arizona
Peking Union Medical College Hospital
St. Jude Children's Research Hospital
University of Maryland, Baltimore
Australian & New Zealand Children's Haematology/Oncology Group
Gustave Roussy, Cancer Campus, Grand Paris
M.D. Anderson Cancer Center
Jaime Leandro Foundation for Therapeutic Cancer Vaccines
UNC Lineberger Comprehensive Cancer Center
Pardis Noor Medical Imaging and Cancer Center
Weill Medical College of Cornell University
National University Hospital, Singapore
University of Maryland, Baltimore
University of Kansas Medical Center
University of California, San Diego
Zhejiang University
Cancer Research UK
University of Rochester
NuCana plc
Queen's University
Yonsei University
D'Or Institute for Research and Education
Brigham and Women's Hospital
AHS Cancer Control Alberta
Cancer Research UK
Cancer Research UK
University Medical Center Groningen
University of Manitoba
Medical College of Wisconsin
Thomas Jefferson University
Thomas Jefferson University
Hiroshima University Hospital
University Hospital, Basel, Switzerland
Northwell Health
Northwell Health
Northwell Health
CHU de Quebec-Universite Laval
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center